In 2018, after 23 years as a Navy SEAL, Jon Dalton retired and turned his attention to a new struggle: living with depression and anxiety.

For decades, the federal government considered marijuana as dangerous a drug as heroin. That changed Thursday when the acting U.S. Attorney General Todd Blanchard signed an order reclassifying state-licensed cannabis products from schedule I to a far less regulated schedule III. The order does not legalize marijuana for medical or recreational use under federal law, but it does ease some barriers to cannabis research. And that came as very good news for a pair of UNLV scientists.

What's the first thing you did today? You may have hit the gym, made a nutritious breakfast, or rushed out the door to work, but I bet my bottom dollar that it was preceded by a five minute scroll on your phone — am I right?

The clock ticks past 2am. Your body is screaming for rest, but your brain just won’t quit. Instead, it replays every embarrassing thing you’ve said in the past ten years or plans for unlikely worst case scenarios. Plus, the lack of sleep will only make the anxiety worse tomorrow. You definitely need something to break the cycle, but the search for the best sleep aid for adults with anxiety has only added more anxiety and overwhelm to your plate so far.

Emerging studies show possible links between certain sweeteners — including erythritol — and faster cognitive decline, though scientists caution the research is still early.

Researchers at UNLV are trying to determine if a kitchen spice could become a way to treat seizures.

Within the white, clinical walls of a nondescript UNLV lab, a small team of neuroscientists are working on a project with potentially big implications for children suffering from seizures.

Dr. Dustin Hines, professor of neuroscience at University of Nevada, Las Vegas (UNLV), US, and study co-author Rochelle Hines, professor of psychology, discuss a breakthrough in seizure therapy using compounds derived from caraway seeds. By altering the shape of the seed’s main chemical component, researchers created a new class of THC-free “CBD-like” therapies that showed seizure-reducing effects and promoted healthier brain cell development in preclinical trials, potentially offering safer alternatives to current drug-resistant therapies.